Disease-Modifying Agents in Progressive Multiple Sclerosis: Management of 100 Patients at Louis Stokes Cleveland VAMC, Spinal Cord Injury Division

Journal of Rehabilitation Research and Development - United States
doi 10.1682/jrrd.2010.10.0200
Full Text
Abstract

Available in full text

Categories
Rehabilitation
Date
Authors
Publisher

Journal of Rehabilitation Research & Development

Related search

Hypogammaglobulinemia in Multiple Sclerosis Patients Receiving Disease-Modifying Immunomodulatory Agents

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Characteristics of Pediatric Patients With Relapsing Remitting Multiple Sclerosis Taking Disease Modifying Agents

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Bone and Soft Tissue Changes in Patients With Spinal Cord Injury and Multiple Sclerosis

Folia Medica
Medicine
2014English

Descriptive Evalaution of Characteristics of Patients Diagnosed With Relapsing Remitting Multiple Sclerosis and Taking Disease Modifying Agents

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Infections in Patients With Multiple Sclerosis: Implications for Disease-Modifying Therapy

Acta Neurologica Scandinavica
MedicineNeurology
2017English

Multiple Sclerosis Following a Spinal Cord Injury: A Rare and Unfortunate Case

Spinal cord series and cases
Medicine
2016English

Gut Dysfunction in Patients With Multiple Sclerosis and the Role of Spinal Cord Involvement in the Disease

European Journal of Gastroenterology and Hepatology
HepatologyGastroenterology
2013English

Vesicoureteral Reflux and Bladder Management in Spinal Cord Injury Patients

Spinal Cord
MedicineNeurologyRehabilitation
2002English

Multiple Sclerosis Disease-Modifying Therapy and Pregnancy

Multiple Sclerosis
Neurology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy